Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre Sepriano

Showing results (71-80 of 121) with videos related to

Pageof 13
Sort By:
ARP Rheumatology|July 9, 2025
Translation and cross-cultural adaptation of the mSQUASH into European PortugueseAna Catarina Moniz, Mariana Emília Santos, Kaylene de Freitas, et al.
RMD Open|September 16, 2020
Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisationsAurélie Najm, Marie Kostine, John D Pauling, et al.
RMD Open|July 5, 2023
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trialRosalinde Stal, Sofia Ramiro, Desirée van der Heijde, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|February 13, 2025
1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritisDésirée van der Heijde, Victoria Navarro-Compán, Robert Landewé, et al.
Bone|September 15, 2012
Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fracturesAna M Rodrigues, Joana Caetano-Lopes, Ana C Vale, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.
Acta Reumatologica Portuguesa|June 29, 2019
Predictors and causes of first-line biologic agent discontinuation in rheumatoid arthritis: data from Reuma.ptJoao Lagoas Gomes, Alexandre Sepriano, Mónica Eusébio, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|March 17, 2017
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritisSofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, et al.
Pageof 13

Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
ARP Rheumatology|July 9, 2025
Translation and cross-cultural adaptation of the mSQUASH into European PortugueseAna Catarina Moniz, Mariana Emília Santos, Kaylene de Freitas, et al.
RMD Open|September 16, 2020
Multidisciplinary collaboration among young specialists: results of an international survey by the emerging EULAR network and other young organisationsAurélie Najm, Marie Kostine, John D Pauling, et al.
RMD Open|July 5, 2023
Do fatty lesions explain the effect of inflammation on new syndesmophytes in patients with radiographic axial spondyloarthritis? Results from the SIAS cohort and ASSERT trialRosalinde Stal, Sofia Ramiro, Desirée van der Heijde, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2019 update of the EULAR recommendations for the management of rheumatoid arthritisAlexandre Sepriano, Andreas Kerschbaumer, Josef S Smolen, et al.
Annals of the Rheumatic Diseases|February 13, 2025
1995-2025: thirty years of ASAS and its contribution to the understanding of spondyloarthritisDésirée van der Heijde, Victoria Navarro-Compán, Robert Landewé, et al.
Bone|September 15, 2012
Low osteocalcin/collagen type I bone gene expression ratio is associated with hip fragility fracturesAna M Rodrigues, Joana Caetano-Lopes, Ana C Vale, et al.
Annals of the Rheumatic Diseases|February 9, 2020
Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritisAndreas Kerschbaumer, Alexandre Sepriano, Josef S Smolen, et al.
Acta Reumatologica Portuguesa|June 29, 2019
Predictors and causes of first-line biologic agent discontinuation in rheumatoid arthritis: data from Reuma.ptJoao Lagoas Gomes, Alexandre Sepriano, Mónica Eusébio, et al.
Annals of the Rheumatic Diseases|June 4, 2018
Work participation in spondyloarthritis across countries: analysis from the ASAS-COMOSPA studySantiago Rodrigues Manica, Alexandre Sepriano, Sofia Ramiro, et al.
Annals of the Rheumatic Diseases|March 17, 2017
Safety of synthetic and biological DMARDs: a systematic literature review informing the 2016 update of the EULAR recommendations for management of rheumatoid arthritisSofia Ramiro, Alexandre Sepriano, Katerina Chatzidionysiou, et al.
Pageof 13